Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$240,326,222
-$33,992,349 QoQ
Shares Held
9,980,325
+2.2% QoQ
Ownership
0.175%
of shares outstanding
% of Portfolio
0.27%
of 13F equity value
Holder Rank
#60
of 2,812 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $5,426,093,696 across 17 Drug Manufacturers - General names. PFE ranks #6 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,454,737 | $1,131,369,551 | |
| 2 | MRK |
Merck & Co., Inc.
|
8,169,394 | $1,049,767,127 | |
| 3 | LLY |
ELI LILLY & Co
|
786,902 | $943,833,942 | |
| 4 | ABBV |
AbbVie Inc.
|
3,625,155 | $912,234,002 | |
| 5 | AMGN |
Amgen Inc
|
1,548,229 | $560,644,681 | |
| 6 | PFE |
Pfizer Inc
This page
|
9,980,325 | $240,326,222 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,152,519 | $145,609,245 | |
| 8 | AZN |
Astrazeneca PLC
|
670,847 | $127,206,004 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,326,222 | 9,980,325 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $274,318,571 | 9,769,180 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $231,006,287 | 9,277,361 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $238,337,291 | 9,353,897 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $228,036,245 | 9,407,436 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $240,339,457 | 9,484,588 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $241,099,436 | 9,087,804 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $271,320,657 | 9,375,282 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $243,062,760 | 8,687,018 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $231,444,321 | 8,340,336 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $202,573,720 | 7,036,253 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $455,610,977 | 13,735,634 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $486,765,419 | 13,270,595 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $526,909,925 | 12,914,459 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $624,928,467 | 12,196,106 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $518,887,040 | 11,857,565 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $672,174,671 | 12,820,421 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $637,318,153 | 12,310,569 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $697,337,566 | 11,809,273 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $504,588,799 | 11,731,895 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $442,534,977 | 11,300,689 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $392,169,493 | 10,824,441 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $397,488,695 | 10,798,389 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $376,340,877 | 10,254,530 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $316,580,207 | 9,681,342 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $302,352,459 | 9,263,262 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||